Madhu Chintala

1.9k total citations
50 papers, 1.4k citations indexed

About

Madhu Chintala is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Madhu Chintala has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 25 papers in Cardiology and Cardiovascular Medicine and 18 papers in Genetics. Recurrent topics in Madhu Chintala's work include Blood Coagulation and Thrombosis Mechanisms (28 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers) and Antiplatelet Therapy and Cardiovascular Diseases (12 papers). Madhu Chintala is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (28 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (18 papers) and Antiplatelet Therapy and Cardiovascular Diseases (12 papers). Madhu Chintala collaborates with scholars based in United States, United Kingdom and Belgium. Madhu Chintala's co-authors include Yunsheng Hsieh, Ho-Sam Ahn, William J. Greenlee, Samuel Chackalamannil, Carolyn Foster, George Boykow, Yan Xia, Jacqueline Agans-Fantuzzi, Stan Kurowski and Ying Zhai and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Madhu Chintala

48 papers receiving 1.4k citations

Peers

Madhu Chintala

CCM

HEMAT

GENET

Christer Mattsson Sweden

Taketoshi Ogawa Japan

George Boykow United States

Atsuhiro Sugidachi Japan

P.D. Winocour Canada

Jean‐Marie Pereillo France

Ross Bentley United States

Johannes Ruef Germany

Benjamin E. Tourdot United States

Earl J. Crain United States

Christer Mattsson Sweden

Madhu Chintala

570 ×0.9

CCM

671 ×1.3

HEMAT

204 ×0.6

70 ×0.3

87 ×0.5

GENET

Citations per year, relative to Madhu Chintala Madhu Chintala (= 1×) peers Christer Mattsson

Countries citing papers authored by Madhu Chintala

Since Specialization

Citations

This map shows the geographic impact of Madhu Chintala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madhu Chintala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madhu Chintala more than expected).

Fields of papers citing papers by Madhu Chintala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madhu Chintala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madhu Chintala. The network helps show where Madhu Chintala may publish in the future.

Co-authorship network of co-authors of Madhu Chintala

This figure shows the co-authorship network connecting the top 25 collaborators of Madhu Chintala. A scholar is included among the top collaborators of Madhu Chintala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madhu Chintala. Madhu Chintala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xinkang, et al.. (2023). Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous Thrombosis. SHILAP Revista de lepidopterología. 7(2). e97–e104. 3 indexed citations

Du, Fuyong, et al.. (2019). Pharmacological Profile of JNJ-64179375: A Novel, Long-Acting Exosite-1 Thrombin Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 371(2). 375–384. 1 indexed citations

Chintala, Madhu, et al.. (2017). Preferential Inhibition of Fibrin Mediated Thrombosis in Rodent Models By JNJ-9375, a Novel exosite1 Thrombin Inhibitor. Blood. 130. 3712. 1 indexed citations

Cai, Tian‐Quan, L. Alexandra Wickham, Gary R. Sitko, et al.. (2015). Platelet transfusion reverses bleeding evoked by triple anti-platelet therapy including vorapaxar, a novel platelet thrombin receptor antagonist. European Journal of Pharmacology. 758. 107–114. 13 indexed citations

Shang, Jin, Min Wang, Qiu Li, et al.. (2014). Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the Arterio-Venous shunt model of thrombosis. Thrombosis Research. 134(2). 433–439. 16 indexed citations

Xu, Yiming, Weizhen Wu, Liangsu Wang, et al.. (2013). Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro. Blood Coagulation & Fibrinolysis. 24(3). 332–338. 43 indexed citations

Chackalamannil, Samuel, Yan Xia, Keith Eagen, et al.. (2012). Discovery of nor-seco himbacine analogs as thrombin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(7). 2544–2549. 11 indexed citations

Wang, Junru, Ashwini Kulkarni, Madhu Chintala, Louis M. Fink, & Martin Hauer‐Jensen. (2012). Inhibition of Protease-activated Receptor 1 Ameliorates Intestinal Radiation Mucositis in a Preclinical Rat Model. International Journal of Radiation Oncology*Biology*Physics. 85(1). 208–214. 6 indexed citations

Huang, Xianhai, Jing Su, Wei Zhou, et al.. (2011). SAR studies of C2 ethers of 2H-pyrano[2,3-d]pyrimidine-2,4,7(1H,3H)-triones as nicotinic acid receptor (NAR) agonist. Bioorganic & Medicinal Chemistry Letters. 22(2). 854–858. 12 indexed citations

10.

Xia, Yan, Samuel Chackalamannil, William J. Greenlee, et al.. (2010). Discovery of a vorapaxar analog with increased aqueous solubility. Bioorganic & Medicinal Chemistry Letters. 20(22). 6676–6679. 19 indexed citations

11.

Chintala, Madhu, et al.. (2008). Basic and Translational Research on Proteinase-Activated Receptors: Antagonism of the Proteinase-Activated Receptor 1 for Thrombin, a Novel Approach to Antiplatelet Therapy for Atherothrombotic Disease. Journal of Pharmacological Sciences. 108(4). 433–438. 42 indexed citations

12.

Chackalamannil, Samuel, Yan Xia, William J. Greenlee, et al.. (2005). Discovery of Potent Orally Active Thrombin Receptor (Protease Activated Receptor 1) Antagonists as Novel Antithrombotic Agents. Journal of Medicinal Chemistry. 48(19). 5884–5887. 106 indexed citations

13.

Wang, Yuguang, Samuel Chackalamannil, Zhiyong Hu, et al.. (2002). Design and synthesis of xanthine analogues as potent and selective PDE5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(21). 3149–3152. 29 indexed citations

14.

Hsieh, Yunsheng, Madhu Chintala, Mei Hong, et al.. (2001). Quantitative screening and matrix effect studies of drug discovery compounds in monkey plasma using fast‐gradient liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 15(24). 2481–2487. 108 indexed citations

15.

Foster, Carolyn, Ying Zhai, Michelle Smith, et al.. (2001). Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. Journal of Clinical Investigation. 107(12). 1591–1598. 330 indexed citations

16.

Chintala, Madhu, et al.. (1998). Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats. European Journal of Pharmacology. 349(2-3). 237–243. 9 indexed citations

17.

Chiu, Peter J.S., Glen Tetzloff, Carolyn Foster, Madhu Chintala, & Edmund J. Sybertz. (1997). Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs. European Journal of Pharmacology. 321(1). 129–135. 7 indexed citations

18.

Jacinto, Severina M., Madhu Chintala, Mustafa F. Lokhandwala, & Bhagavan S. Jandhyala. (1997). Efficacy and Mechanisms of Dopexamine in the Prevention of Ischemia-Reperfusion Induced Organ Damage: Role of Oxygen Free Radicals. Clinical and Experimental Hypertension. 19(1-2). 181–190. 9 indexed citations

19.

Vemulapalli, Subbarao, Robert W. Watkins, Madhu Chintala, et al.. (1996). Antiplatelet and Antiproliferative Effects of SCH 51866, a Novel Type 1 and Type 5 Phosphodiesterase Inhibitor. Journal of Cardiovascular Pharmacology. 28(6). 862–869. 45 indexed citations

20.

Chintala, Madhu, M F Lokhandwala, & Bhagavan S. Jandhyala. (1990). Protective effects of dopexamine hydrochloride in renal failure after acute haemorrhage in anaesthetized dogs. Journal of Autonomic Pharmacology. 10(s1). s95–102. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact